Paula Kage1, Laura Poblotzki1, Samira Zeynalova2,3, Julia Zarnowski1, Jan-Christoph Simon1,2, Regina Treudler1,2. 1. Department of Dermatology, Venereology and Allergology, UMC Leipzig, Leipzig, Germany. 2. LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. 3. Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
Abstract
BACKGROUND: Atopic eczema (AE) is known to be associated with depression and anxiety. We aimed at investigating the occurrence of selected psychological comorbidities in patients with AE under treatment in our university dermatological department. METHODS: Monocentric prospective examination of adult AE patients using PO-SCORAD (Patient-Oriented Severity Scoring of AD), EASI (Eczema Area and Severity Index), POEM (Patient-Oriented Eczema Measure), DLQI (Dermatologic Life Quality Index), LSNS-6 (Lubben Social Network Scale 6), CES-D (Center for Epidemiologic Studies Depression Scale), HADS-D and -A (Hospital Anxiety and Depression Scale), and GAD-7 (Generalized Anxiety Disorder Scale-7) was carried out. We looked for correlations between AE severity and psychosocial comorbidities. Data were compared with age- and sex-matched controls from nonatopic subjects. STATISTICS: Mann-Whitney U test and Spearman's rank correlation were used. RESULTS: Eighty-four patients (44 women, median age 35.0 years, range: 19.4-92.8 years) were included. PO-SCORAD was 40.4 [23.4-55.4] (median [interquartile range]), EASI 9.3 [3.4-18.9], POEM 16 [8-24], and DLQI 10 [4-18]. Compared with 161 from the healthy LIFE-Adult cohort controls, our patients with AE had significantly higher scores for HADS, GAD-7, and CES-D (p < 0.001, respectively), but there was no increase in the LSNS score (18 vs. 19; p = 0.067). Within the group of AE patients, there was a significant correlation of the subjective skin severity and the depression and anxiety values: POEM significantly correlated with GAD-7, CES-D, and HADS-A and -D (p < 0.001). PO-SCORAD significantly correlated with GAD-7 and CES-D (p < 0.05). EASI correlated neither with HADS-A or -D nor with CES-D. Patients with suicidal thoughts, plans, or attempts in the last 12 months had significantly more severe AE than those without (POEM 25 [15.3-26] vs. 15 [7-23]; p = 0.013, and PO-SCORAD 51.6 [40.2-63] vs. 20.5 [20.7-52]; p = 0.014). CONCLUSION: Patients with AE being currently under treatment in our department had significantly increased scores indicating depression and anxiety. Suicidal tendency was increased in patients with severe AE. KEY MESSAGE: AE patients may develop depression, anxiety, and suicidal ideation. Patient-oriented scores may help identifying high-risk patients.
BACKGROUND: Atopic eczema (AE) is known to be associated with depression and anxiety. We aimed at investigating the occurrence of selected psychological comorbidities in patients with AE under treatment in our university dermatological department. METHODS: Monocentric prospective examination of adult AE patients using PO-SCORAD (Patient-Oriented Severity Scoring of AD), EASI (Eczema Area and Severity Index), POEM (Patient-Oriented Eczema Measure), DLQI (Dermatologic Life Quality Index), LSNS-6 (Lubben Social Network Scale 6), CES-D (Center for Epidemiologic Studies Depression Scale), HADS-D and -A (Hospital Anxiety and Depression Scale), and GAD-7 (Generalized Anxiety Disorder Scale-7) was carried out. We looked for correlations between AE severity and psychosocial comorbidities. Data were compared with age- and sex-matched controls from nonatopic subjects. STATISTICS: Mann-Whitney U test and Spearman's rank correlation were used. RESULTS: Eighty-four patients (44 women, median age 35.0 years, range: 19.4-92.8 years) were included. PO-SCORAD was 40.4 [23.4-55.4] (median [interquartile range]), EASI 9.3 [3.4-18.9], POEM 16 [8-24], and DLQI 10 [4-18]. Compared with 161 from the healthy LIFE-Adult cohort controls, our patients with AE had significantly higher scores for HADS, GAD-7, and CES-D (p < 0.001, respectively), but there was no increase in the LSNS score (18 vs. 19; p = 0.067). Within the group of AE patients, there was a significant correlation of the subjective skin severity and the depression and anxiety values: POEM significantly correlated with GAD-7, CES-D, and HADS-A and -D (p < 0.001). PO-SCORAD significantly correlated with GAD-7 and CES-D (p < 0.05). EASI correlated neither with HADS-A or -D nor with CES-D. Patients with suicidal thoughts, plans, or attempts in the last 12 months had significantly more severe AE than those without (POEM 25 [15.3-26] vs. 15 [7-23]; p = 0.013, and PO-SCORAD 51.6 [40.2-63] vs. 20.5 [20.7-52]; p = 0.014). CONCLUSION: Patients with AE being currently under treatment in our department had significantly increased scores indicating depression and anxiety. Suicidal tendency was increased in patients with severe AE. KEY MESSAGE: AE patients may develop depression, anxiety, and suicidal ideation. Patient-oriented scores may help identifying high-risk patients.
Authors: S Weidinger; J Schmitt; T Werfel; A Heratizadeh; E Haufe; D Stölzl; S Abraham; L Heinrich; A Kleinheinz; A Wollenberg; E Weisshaar; M Augustin; F Wiemers; A Zink; R von Kiedrowski; M Hilgers; M Worm; M Pawlak; M Sticherling; I Fell; C Handrick; K Schäkel; P Staubach-Renz; A Asmussen; B Schwarz; M Bell; I Effendy; T Bieber; B Homey; B Gerlach; E Tchitcherina; M Stahl; U Schwichtenberg; J Rossbacher; P Buck; M Mempel; S Beissert; T Biedermann Journal: J Eur Acad Dermatol Venereol Date: 2020-02-13 Impact factor: 6.166
Authors: J Ring; A Zink; B W M Arents; I A Seitz; U Mensing; M C Schielein; N Wettemann; G de Carlo; A Fink-Wagner Journal: J Eur Acad Dermatol Venereol Date: 2019-06-06 Impact factor: 6.166
Authors: Markus Loeffler; Christoph Engel; Peter Ahnert; Dorothee Alfermann; Katrin Arelin; Ronny Baber; Frank Beutner; Hans Binder; Elmar Brähler; Ralph Burkhardt; Uta Ceglarek; Cornelia Enzenbach; Michael Fuchs; Heide Glaesmer; Friederike Girlich; Andreas Hagendorff; Madlen Häntzsch; Ulrich Hegerl; Sylvia Henger; Tilman Hensch; Andreas Hinz; Volker Holzendorf; Daniela Husser; Anette Kersting; Alexander Kiel; Toralf Kirsten; Jürgen Kratzsch; Knut Krohn; Tobias Luck; Susanne Melzer; Jeffrey Netto; Matthias Nüchter; Matthias Raschpichler; Franziska G Rauscher; Steffi G Riedel-Heller; Christian Sander; Markus Scholz; Peter Schönknecht; Matthias L Schroeter; Jan-Christoph Simon; Ronald Speer; Julia Stäker; Robert Stein; Yve Stöbel-Richter; Michael Stumvoll; Attila Tarnok; Andrej Teren; Daniel Teupser; Francisca S Then; Anke Tönjes; Regina Treudler; Arno Villringer; Alexander Weissgerber; Peter Wiedemann; Silke Zachariae; Kerstin Wirkner; Joachim Thiery Journal: BMC Public Health Date: 2015-07-22 Impact factor: 3.295